Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-Analysis
Small cell lung cancer (SCLC) is an aggressive neuroendocrine carcinoma with early metastatic potential. The standard-of-care treatment has not changed in years. Recent studies report improved progression-free survival (PFS) and overall survival (OS) with combined ICI and chemotherapy in ES-SCLC. We...
Gardado en:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI AG
2022-11-01
|
| Series: | Current Oncology |
| Assuntos: | |
| Acceso en liña: | https://www.mdpi.com/1718-7729/29/12/709 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|